Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02844660 · ClinicalTrials.gov registry record · NA
Dehydrated Human Umbilical Cord Allograft in the Management of Diabetic Foot Ulcers
A NA study, sponsored by MiMedx Group.
- Completed
- Registry status
- NA
- Development phase
- 130
- Enrollment target
NCT02844660 is a NA study that has completed, run by MiMedx Group. The registered enrollment target is 130 participants.
The verdict
NCT02844660, a NA study, has completed, sponsored by MiMedx Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
Study Summary
A Multicenter, Prospective, Randomized Controlled Comparative Parallel Study To determine the safety and effectiveness of EpiCord as compared to standard of care (SOC) therapy for the treatment of chronic, non-healing diabetic foot ulcers (DFUs)
Interventions
- OTHER Standard of Care
- BIOLOGICAL EpiCord
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2016-07 |
| Est. Completion | 2018-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02844660
The ClinicalTrials.gov registry entry for NCT02844660 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MiMedx Group, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT02844660 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02844660 about?
NCT02844660 is a clinical study titled "Dehydrated Human Umbilical Cord Allograft in the Management of Diabetic Foot Ulcers". A Multicenter, Prospective, Randomized Controlled Comparative Parallel Study To determine the safety and effectiveness of EpiCord as compared to standard of care (SOC) therapy for the treatment of chronic, non-healing diabetic foot ulcers (DFUs)
What is the current status of trial NCT02844660?
This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2016-07. Estimated completion is 2018-07.
What interventions are being tested in trial NCT02844660?
The interventions under investigation include: Standard of Care (OTHER), EpiCord (BIOLOGICAL).
Who is sponsoring clinical trial NCT02844660?
This trial is sponsored by MiMedx Group, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.